UK Approves Marstacimab for Severe Haemophilia A or B ...Middle East

The UK medicines regulator has approved Pfizer’s marstacimab for patients aged 12 years or older with severe haemophilia A or B, offering a new subcutaneous treatment option. Medscape News UK

Hence then, the article about uk approves marstacimab for severe haemophilia a or b was published today ( Friday 25/04/2025 - 09:59 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( UK Approves Marstacimab for Severe Haemophilia A or B )

Also on site :

• Human heads displayed at Ecuador tourist beach in warning to gangs
• Nazi salutes and drug cartels: Dutch mercenary recounts service with Kiev’s military
• Macy’s Valley Fair shoppers thwart Rolex watch thieves